** Shares of Kleenex tissue maker Kimberly-Clark KMB.N down ~2% at $125.25 premarket
** Brokerage TD Cowen lowers rating to "hold" from "buy", cuts PT to $145 from $159
** Brokerage expects gross margin expansion in 2025 to slow down as benefits from commodity cost deflation in pulp and paper are beginning to reverse
** External factors like hurricanes, shifts in trade inventory, slowdown in professional market seem to be impacting KMB's organic growth more profoundly than its peers - brokerage
** Six of 20 brokerages rate the stock "buy" or "higher", 12 "hold" and two "sell" or "lower"; median PT is $150 - LSEG
** KMB rose about 8% in 2024
(Reporting by Anuja Bharat Mistry in Bengaluru)
((AnujaBharat.Mistry@thomsonreuters.com;))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。